tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Laura Prendergast, 19 are a BUY (90.48%), 2 are a HOLD (9.52%).
Analyst Laura Prendergast, currently employed at STIFEL, carries an average stock price target met ratio of 53.1% that have a potential upside of 43.42% achieved within 82 days. Previously, Laura Prendergast worked at RAYMOND JAMES.
Laura Prendergast’s has documented 41 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RVMD, Revolution Medicines.
Analyst best performing recommendations are on ERAS (ERASCA).
The best stock recommendation documented was for ERAS (ERASCA) at 11/6/2025. The price target of $6 was fulfilled within 64 days with a profit of $3.76 (167.86%) receiving and performance score of 26.23.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Nov-2023
$11
$9.29 (543.27%)
$10
4 months 17 days ago
(29-Apr-2026)
0/13 (0%)
$8.43 (328.02%)
Buy Since 12-Sep-2023
$14
$12.29 (718.71%)
$16
5 months 29 days ago
(17-Mar-2026)
0/10 (0%)
$11.77 (527.80%)
Buy Since 18-Nov-2025
$8
$6.29 (367.84%)
$9
7 months 30 days ago
(16-Jan-2026)
0/2 (0%)
$5.44 (212.50%)
Buy Since 14-Dec-2023
9 months 11 days ago
(04-Dec-2025)
1/6 (16.67%)
$5.12 (177.78%)
83
Buy Since 31-Jul-2024
$8
10 months 30 days ago
(16-Oct-2025)
0/2 (0%)
$3.85 (92.77%)
Which stock is Laura Prendergast most bullish on?
Which stock is Laura Prendergast most reserved on?
What Year was the first public recommendation made by Laura Prendergast?
